ADC is named as a drug or biological intervention in 6 clinical trials in our China and USA trial registers, 3 of which are recruiting. Lead sponsors include Fudan University (2), MBrace Therapeutics (1) and Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1). Registered phases: Phase 2, Phase 1/2 and Observational. Conditions studied include Breast Cancer; Prostate Cancer Castration-resistant Prostate Cancer; Colo-rectal Cancer.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Breast Cancer | 2 |
| Prostate Cancer Castration-resistant Prostate Cancer | 1 |
| Colo-rectal Cancer | 1 |
| Lung Cancer (Non-Small Cell) | 1 |
| Metastatic Triple-negative Breast Cancer | 1 |
| Urothelial Carcinoma of the Renal Pelvis and Ureter | 1 |
| Neoadjuvant Therapy | 1 |
| Metastatic Breast Cancer ( HER2 Negative) | 1 |
| ctDNA | 1 |
| Carcinoma | 1 |
| Solid Tumor | 1 |
| Lead sponsor | Trials |
|---|---|
| Fudan University | 2 |
| MBrace Therapeutics | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Peking University First Hospital | 1 |
| Second Affiliated Hospital of Soochow University | 1 |
| Register | ADC trials |
|---|---|
| Clinical trials in China | 5 |
| Clinical trials in USA | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how ADC works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists ADC (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.